Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV-Associated Lipodystrophy Syndrome”

32 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 32 results

Large-scale testing (Phase 3)Study completedNCT00383734
What this trial is testing

Safety and Efficacy of Intradermal Injections of Newfill Versus Eutrophill in the Treatment of Facial Lipoatrophy in HIV-infected Patients ANRS 132 SMILE

Who this might be right for
HIV-Associated Lipodystrophy Syndrome
French National Agency for Research on AIDS and Viral Hepatitis 148
Large-scale testing (Phase 3)Study completedNCT01077765
What this trial is testing

Polyacrylamide Hydrogel Injection in HIV-related Lipoatrophy

Who this might be right for
HIV InfectionAntiretroviral Side EffectsLipodystrophy Syndrome Related to HIV Infection
Assistance Publique - Hôpitaux de Paris 100
Post-approval studies (Phase 4)Ended earlyNCT00126308
What this trial is testing

Facial Lipoatrophy Trial: Immediate Versus Deferred Injections of Poly-L-Lactic Acid for HIV Facial Lipoatrophy

Who this might be right for
HIV-Associated LipodystrophyHIV Infections
Kirby Institute 100
Testing effectiveness (Phase 2)Study completedNCT00130286
What this trial is testing

Growth Hormone and/or Rosiglitazone for HIV-Associated Increased Abdominal Fat and Insulin Resistance

Who this might be right for
HIV-Associated Lipodystrophy SyndromeInsulin ResistanceHIV Infections+2 more
Weill Medical College of Cornell University 77
Post-approval studies (Phase 4)Ended earlyNCT00122668
What this trial is testing

Evaluation of the Occurrence of Lipoatrophy in HIV-1 Infected Naive Patients

Who this might be right for
HIV InfectionsHIV-Associated Lipodystrophy Syndrome
French National Agency for Research on AIDS and Viral Hepatitis 112
Not applicableStudy completedNCT00069004
What this trial is testing

Physical and Metabolic Abnormalities in HIV Infected and Uninfected Children and Youth

Who this might be right for
HIV InfectionsHIV-Associated Lipodystrophy SyndromeHIV Lipodystrophy Syndrome+4 more
National Institute of Allergy and Infectious Diseases (NIAID) 450
Not applicableStudy completedNCT01405456
What this trial is testing

Eplerenone in HIV Associated Abdominal Fat Accumulation

Who this might be right for
HIV
Massachusetts General Hospital 46
Post-approval studies (Phase 4)Study completedNCT04340388
What this trial is testing

Contribution of Dolutegravir to Obesity and Cardiovascular Disease

Who this might be right for
HIV-1-infectionAntiviral Drug Adverse ReactionVascular Diseases+5 more
Augusta University 10
Post-approval studies (Phase 4)UnknownNCT00122226
What this trial is testing

MEDICLAS Study (Metabolic Effects of Different Classes of AntiretroviralS)

Who this might be right for
HIV InfectionsHIV-Associated Lipodystrophy Syndrome
Amsterdam UMC, location VUmc 50
Not applicableStudy completedNCT00246402
What this trial is testing

Acipimox to Improve Hyperlipidemia and Insulin Sensitivity Associated With HIV

Who this might be right for
Insulin ResistanceCardiovascular DiseasesHeart Diseases+3 more
National Heart, Lung, and Blood Institute (NHLBI) 30
Not applicableStudy completedNCT05383456
What this trial is testing

The Visceral Adiposity Measurement and Observation Study

Who this might be right for
HIVHIV-InfectionsHIV-1-infection+16 more
Theratechnologies 196
Post-approval studies (Phase 4)Study completedNCT00135356
What this trial is testing

Study of Reyataz in HIV-infected Patients With Lipodystrophy Syndrome

Who this might be right for
HIV-Associated Lipodystrophy Syndrome
Bristol-Myers Squibb 219
Post-approval studies (Phase 4)Study completedNCT00646984
What this trial is testing

Strategies of Interruption/Reinitiation of Antiretroviral Therapy in HIV-Infected Patients With Lipodystrophy

Who this might be right for
HIV-Associated Lipodystrophy Syndrome
Hospital Clinic of Barcelona 147
Testing effectiveness (Phase 2)Study completedNCT00461552
What this trial is testing

Therapeutic Approaches to HAART-Induced Lipodystrophy

Who this might be right for
HIV InfectionsLipodystrophy
University of Texas Southwestern Medical Center 23
Post-approval studies (Phase 4)UnknownNCT00135460
What this trial is testing

Comparing a Nucleoside-Analogue-Sparing Regimen and a Protease-Inhibitor-Sparing Regimen in HIV Infected Patients

Who this might be right for
HIV-Associated Lipodystrophy Syndrome
Danish HIV Research Group 100
Not applicableStudy completedNCT01359917
What this trial is testing

Psychological Morbidity and Facial Volume in HIV Lipodystrophy: Quantification of Treatment Outcome

Who this might be right for
HIV-Associated Lipodystrophy Syndrome
NHS Lothian 50
Post-approval studies (Phase 4)Study completedNCT00139178
What this trial is testing

Switching From Zidovudine to an NNRTI or Lopinavir/Ritonavir in Patients Treated With Zidovudine/ Lamivudine/Abacavir.

Who this might be right for
HIV Associated Lipodystrophy Syndrome.HIVHypercholesterolemia+1 more
Danish HIV Research Group 100
Large-scale testing (Phase 3)Study completedNCT00608023
What this trial is testing

TH9507 Extension Study in Patients With HIV-Associated Lipodystrophy

Who this might be right for
LipodystrophyHIV Infections
Theratechnologies 263
Large-scale testing (Phase 3)Ended earlyNCT00148850
What this trial is testing

Effect of Pioglitazone on HIV-1 Related Lipoatrophy: a Randomized, Double Blind, Placebo-Controlled Trial in 130 Patients

Who this might be right for
HIV-Associated Lipodystrophy SyndromeHIV Infections
French National Agency for Research on AIDS and Viral Hepatitis 130
Early research (Phase 1)Study completedNCT01848340
What this trial is testing

Investigate the Recovery, Excretion, and Pharmacokinetics of 14C-GSK1265744 Administered as a Single Oral Dose and a Study to Describe the Pharmacokinetics of a Supratherapeutic Dose of GSK1265744 in Healthy Adult Subjects

Who this might be right for
HIV-associated Lipodystrophy Syndrome
ViiV Healthcare 16
Next Page